SALT FORMS OF IRAK4 DEGRADERS

The present disclosure relates generally to various salt forms and compositions thereof useful for the modulation of interleukin-1 receptor-associated kinase 4 ("IRAK4") via ubiquitination and/or degradation and uses of the same in the treatment various diseases. La présente invention conc...

Full description

Saved in:
Bibliographic Details
Main Author HENCKEN, Christopher P
Format Patent
LanguageEnglish
French
Published 18.04.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates generally to various salt forms and compositions thereof useful for the modulation of interleukin-1 receptor-associated kinase 4 ("IRAK4") via ubiquitination and/or degradation and uses of the same in the treatment various diseases. La présente invention concerne de manière générale diverses formes salines et compositions de celles-ci utiles pour la modulation de la kinase 4 associée au récepteur de l'interleukine-1 ("IRAK4") par ubiquitination et/ou dégradation et leurs utilisations dans le traitement de diverses maladies.
Bibliography:Application Number: WO2023US76862